The study, which is being conducted under an FDA-approved Investigational Device Exemption application, held by GRAIL, leverages GRAIL's targeted methylation platform to detect ctDNA. With GRAIL's ...

The global cardiac biomarker diagnostic test kits market is poised for significant growth, with an estimated market size of ...

Good afternoon, ladies and gentlemen. Welcome to Plus Therapeutics Third Quarter 2024 Results Conference Call. Before we begin, we want to advise you that over the course of the call, including any ...

Austrian researchers evaluate MALDI-TOF MS assays for carbapenemase detection, assessing their reliability and practicality ...

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

The Centers for Disease Control and Prevention has signed an agreement with Alveo Technologies to develop a handheld avian ...

Alpha Tech Corp. (AIRE – Research Report), the Real Estate sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Although the future of AI in health care is somewhat predictable, its current application suggests the delivery of patient ...

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

The UK-based firm is developing its initial panel tests for Gram-negative bacteria with tests for Gram-positive bacteria and ...

What’s more, polymerase chain reaction (PCR) is currently the only approved method of diagnosing mpox. It is expensive, ...